Proceedings of the National Academy of Sciences · 2004 · 121 citations · 48 references
MedicineMolecular BiologyOncologyGene ExpressionMolecular OncologyOncogenesCell Cycle DeregulationGene Fusions In CancerOncogenic Signaling PathwaysSignal Transduction In CancerTranscription Factor OncogenesTumor Suppressor GenesAcute Myeloid Leukemia BiologyAcute Myeloid Leukemia ProgressionCorepressor Dysfunction In OncogenesisCorepressor RecruitmentGene Fusion OncogenesisLeukemia-associated Fusion GenesMutagenic MechanismsTranslocation-associated Leukemias
Normal blood-cell differentiation is controlled by regulated gene expression and signal transduction. Transcription deregulation due to chromosomal translocation is a common theme in hematopoietic neoplasms. AML1-ETO, which is a fusion protein generated by the 8;21 translocation that is commonly associated with the development of acute myeloid leukemia, fuses the AML1 runx family DNA-binding transcription factor to the ETO corepressor that associates with histone deacetylase complexes. Analyses have demonstrated that AML1-ETO blocks AML1 function and requires additional mutagenic events to promote leukemia. Here, we report that the loss of the molecular events of AML1-ETO C-terminal NCoR/SMRT-interacting domain transforms AML1-ETO into a potent leukemogenic protein. Contrary to full-length AML1-ETO, the truncated form promotes in vitro growth and does not obstruct the cell-cycle machinery. These observations suggest a previously uncharacterized mechanism of tumorigenesis, in which secondary mutation(s) in molecular events disrupting the function of a domain of the oncogene promote the development of malignancy.
48
A clonogenic common myeloid progenitor that gives rise to all myeloid lineages
Koichi Akashi, David Traver, Toshihiro Miyamoto et al. · Nature · 2000 · 2.6K citations
Life Sciences, Biology, Cell Biology +12